Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 8:3:107.
doi: 10.3389/fimmu.2012.00107. eCollection 2012.

Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer

Affiliations

Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer

Deborah C Rubin et al. Front Immunol. .

Abstract

The inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory disorders of the intestine. The prevalence in the United States is greater than 200 cases per 100,000, with the total number of IBD patients between 1 and 1.5 million. CD may affect all parts of the gastrointestinal tract, from mouth to anus, but most commonly involves the distal part of the small intestine or ileum, and colon. UC results in colonic inflammation that can affect the rectum only, or can progress proximally to involve part of or the entire colon. Clinical symptoms include diarrhea, abdominal pain, gastrointestinal bleeding, and weight loss. A serious long-term complication of chronic inflammation is the development of colorectal cancer. A genetic basis for IBD had long been recognized based on the increased familial risk. However, significant discordance for CD in twins, and a much less robust phenotypic concordance for UC, suggested additional factors play a role in disease pathogenesis, including environmental factors. In the past several years, progress in understanding the molecular basis of IBD has accelerated, beginning with the generation of animal models of colitis and progressing to the identification of specific genetic markers from candidate gene, gene linkage, and genome-wide association analyses. Genetic studies have also resulted in the recognition of the importance of environmental factors, particularly the crucial role of the gut microbiota in CD and UC. Altered immune responses to the normal intestinal flora are key factors in IBD pathogenesis. In this research topic, the genetic basis of IBD, the genetic and cellular alterations associated with colitis-associated colon cancer, and the emerging role of the intestinal microbiota and other environmental factors will be reviewed.

Keywords: Crohn’s disease; chronic intestinal inflammation; colitis-associated colon cancer; inflammatory bowel disease; ulcerative colitis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abraham C., Cho J. H. (2009). Inflammatory bowel disease. N. Engl. J. Med. 361 2066–2078 - PMC - PubMed
    1. Anderson C. A., Massey D. C., Barrett J. C., Prescott N. J., Tremelling M., Fisher S. A., Gwilliam R., Jacob J., Nimmo E. R., Drummond H., Lees C. W., Onnie C. M., Hanson C., Blaszczyk K., Ravindrarajah R., Hunt S., Varma D., Hammond N., Lewis G., Attlesey H., Watkins N., Ouwehand W., Strachan D., McArdle W., Lewis C. M.; Wellcome Trust Case Control Consortium, Lobo, A., Sanderson J., Jewell D. P., Deloukas P., Mansfield J. C., Mathew C. G., Satsangi J., Parkes M. (2009). Investigation of Crohn’s disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136 523–529e3 - PMC - PubMed
    1. Aust D. E., Terdiman J. P., Willenbucher R. F., Chang C. G., Molinaro-Clark A., Baretton G. B., Loehrs U., Waldman F. M. (2002). The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 94 1421–1427 - PubMed
    1. Backhed F., Ley R. E., Sonnenburg J. L., Peterson D. A., Gordon J. I. (2005). Host–bacterial mutualism in the human intestine. Science 307 1915–1920 - PubMed
    1. Barrett J. C., Hansoul S., Nicolae D. L., Cho J. H., Duerr R. H., Rioux J. D., Brant S. R., Silverberg M. S., Taylor K. D., Barmada M. M., Bitton A., Dassopoulos T., Datta L. W., Green T., Griffiths A. M., Kistner E. O., Murtha M. T., Regueiro M. D., Rotter J. I., Schumm L. P., Steinhart A. H., Targan S. R., Xavier R. J.; NIDDK IBD Genetics Consortium, Libioulle, C., Sandor C., Lathrop M., Belaiche J., Dewit O., Gut I., Heath S., Laukens D., Mni M., Rutgeerts P., Van Gossum A., Zelenika D., Franchimont D., Hugot J. P., de Vos M., Vermeire S., Louis E.; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium, Cardon, L. R., Anderson C. A., Drummond H., Nimmo E., Ahmad T., Prescott N. J., Onnie C. M., Fisher S. A., Marchini J., Ghori J., Bumpstead S., Gwilliam R., Tremelling M., Deloukas P., Mansfield J., Jewell D., Satsangi J., Mathew C. G., Parkes M., Georges M., Daly M. J. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40 955–962 - PMC - PubMed
  NODES
Association 3
chat 2
INTERN 4
twitter 2